MUC1 and interstitial lung disease: As a result, the presence of ILD, dcSSc, positive anti-topo I antibodies, negative anticentromere antibodies, an increased ILD extent shown on HRCT, extensive disease, low FVC, low DLCO, a high KL-6 level at baseline and any immunomodulatory treatment were associated with a wide range of variability.